Interactions of Extracellular Matrix Molecules
Three types of molecular interactions are important for the assembly and functioning of extracellular matrices: 1) self-aggregation of the matrix molecules to form ordered structures, 2) the interaction of these molecules with one another to form supramolecular complexes, and 3) their affinity toward cell surfaces to promote attachment of cells to the matrices. Figure 1 depicts some of the features of such interactions as they apply to a fibronectin-containing matrix.
Self-assembly of Extracellular Matrix Molecules
Most, if not all, extracellular matrix molecules have the ability to self-aggregate to form fibrillar meshworks or other structures appropriate for their tissue localization. This process is well known for the interstitial collagens (types H I I) which form fibrils and fibers subsequent to a unique series of posttranslational modifications. Such modifications include hydroxylation of some proline and lysine residues, glycosylation, assembly into triple helices, and removal of peptides from each end of the polypeptide. 6 Type IV collagen, which is specific for basement membranes, differs from the interstitial collagens in that its polypeptide remains uncleaved during processing; also, rather than forming fibrils, it forms "chicken wire" aggregates more suitable for the sheet-like basement membranes. 7 ' 8 Proteoglycans and matrix glycoproteins also show a propensity for self-aggregation. Sulfated proteoglycans can aggregate through interactions of their glycosaminoglycan side chains, 9 and fibronectin and laminin also possess binding sites for other like molecules. 10 " 12 The propensity of fibronectin to self-aggregate may be the basis for the formation of fibrils of insoluble fibronectin around cells.
Purified soluble fibronectin readily forms insoluble aggregates in which the fibronectin molecules are cross-linked to one another by disulfide bonds. 12 Fibronectin made by cells in culture or soluble fibronectin added to such cultures is assembled into orderly fibrillar structures, which resemble the testtube aggregates in being crosslinked. 13 " 16 However, since the fibrillar fibronectin becomes associated with other matrix molecules and because an active participation of the cells is required for this to occur, 16 this fibril formation cannot be entirely due to selfaggregation.
cations separate from collagen. The interactions of matrix molecules with one another and the self-aggregation of individual components thus appear to generate both mixed supramolecular aggregates and homopolymeric structures in the matrix. The resulting matrices then provide a carpet of cell attachment sites with which the cells can interact.
Interactions of Matrix Molecules with One Another
A general characteristic of extracellular matrix molecules appears to be their ability to interact with one or more other matrix macromolecules. Thus, it has been known for some time that proteoglycans bind to collagen and can affect collagen fibrillogene-S j S 17-20 proteoglycans also interact with fibronectin, 20 laminin, 5 vitronectin, 21 and hyaluronic acid. 3 With the exception of the hyaluronic acid binding, these interactions are mediated by the glycoaminoglycan component of the proteoglycan and can be reproduced with pure glycoaminoglycans, particularly heparin.
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" 23 This ability to interact with most neighboring molecules could endow proteoglycans with the properties of a general "glue" in the matrix. The binding of proteoglycans can also affect the biological properties of neighboring matrix molecules, as is exemplified by the inhibition of the cell attachmentpromoting activity of fibronectin and type I collagen by proteoglycans (see the following).
Other interactions of matrix molecules include the binding of fibronectin to collagens. 24 
"
28 Fibronectin binds to a binding site that is present in all types of collagens and in the collagenous domains of the C1 q component of complement and acetylcholinesterase. 4 In type I collagen, the binding site is near the cleavage site for vertebrate collagenase, which is about one-third of the length of the polypeptide from the COOH-terminus. 25 This binding site appears to be more readily available in denatured than in native collagen, since fibronectin greatly favors denatured collagen and binds poorly to native, triple-helical collagen. The interaction with denatured collagen is a strong and specific hydrophobic interaction. This property can be used to purify fibronectin in a single step through affinity chromatography on gelatin (denatured collagen) insolubilized on Sepharose. 24 Despite its in vitro preference for denatured collagen, fibronectin does appear to bind to native collagen as well. That this is the case is strongly suggested by the association of fibronectin and procollagen in cell cultures 27 and by the fact that immunoelectron microscopic staining of tissue sections shows decoration of collagen fibrils with fibronectin in a periodic pattern that is consistent with that of the binding of fibronectin to a particular binding site in the collagen molecule. 28 There may be sufficient "breathing" of the collagen triple helix to allow exposure of the binding site in at least a portion of the molecules which facilitates the subsequent binding of fibronectin. Most of the tissue fibronectin, however, appears to reside in lo-
Cell-Matrlx Interactions
Many of the extracellular matrix components appear to be recognized by receptors at the cell surface. This is true of fibronectin, 4 ' MiM laminin, 31 collagens, 3233 and proteoglycans. 34 When cells interact with a substrate onto which one of these proteins has been immobilized, attachment and spreading occurs. The attachment phenomenon can be easily demonstrated by coating a purified matrix component onto plastic. Cells applied to the dish coated with the matrix protein will attach almost quantitatively to the dish, whereas no cell attachment occurs on control dishes ( Figure 2A ). When purified protein is not available, an adhesive protein can be detected in a protein mixture by separating the mixture by SDS-PAGE followed by transfer of the proteins to a nitrocellulose filter and overlaying of cells onto the filter. 35 Bands of adhesive proteins are visualized by staining the cells attached to the band ( Figure 2B ). Two adhesive plasma proteins are revealed by this technique. One is fibronectin with a molecular mass of 250,000 daltons and the other is vitronectin or serum-spreading factor at about 70,000 daltons.
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Like fibronectin, vitronectin exists in both plasma and tissues and has the ability to promote the adhesion of many different types of cells.
"
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While most cells appear to recognize most of the adhesive matrix proteins, at least to some extent, different cell types show preferences in the adhesion to matrix proteins. This has led to the idea that attachment of cells to the adhesive proteins of extracellular matrix is mediated by cell surface receptors that specifically recognize the cell attachment sites of the matrix proteins. This thinking has focused attention on the cell attachment site-receptor interactions, and the molecular nature of such interactions is beginning to be understood.
Fibronectin Cell Attachment Site
Arglnlne-Glyclne-Aspartlc Acid Recognition Sequence
By isolating progressively smaller cell attachmentpromoting fragments of fibronectin and by synthesizing peptides according to the amino acid sequence of the smallest active fragment, we have been able to show that the cell attachment-promoting activity of fibronectin depends on the tripeptide sequence ArgGly-Asp. A2~iS Similarly, the cell attachment function of vitronectin appears to depend on an Arg-Gly-Asprelated mechanism, because the Arg-Gly-Asp-containing peptides inhibit the attachment of cells to vitronectin. 45 It is obvious that a sequence as short as a tripeptide occurs in a number of proteins other than fibronectin. Collagens promote cell attachment and they also contain numerous Arg-Gly-Asp sequences. 42 However, despite the presence of Arg-Gly-Asp sequences in type I collagen, the attachment of cells to this collagen is not inhibited by the Arg-Gly-Asp peptides at concentrations that are effective against attachment to fibronectin or vitronectin. While this suggests that the Arg-Gly-Asp sequences are not important for the cell attachment function of collagen, it is also possible that Arg-Gly-Asp conformations different from those in fibronectin and different from those favored by the short, synthetic peptides could be important for the cell attachment activity of collagens.
The Arg-Gly-Asp sequence contained in some other proteins, on the other hand, is clearly active. The receptor for the X phage at the surface of E. coli* 6 contains a five-amino acid homology with fibronectin encompassing the Arg-Gly-Asp sequence. This E. coli protein is quite active in promoting attachment of mammalian fibroblasts (reference 42 and unpublished results). Another interesting example of the widespread occurrence of active Arg-GlyAsp sequences is the Dictyostelium discoideum aggregation protein discoidin I, the function of which is inhibited by Arg-Gly-Asp peptides. 47 Among mammalian proteins exhibiting Arg-Gly-Asp-dependent cell surface interactions, fibrinogen is of particular interest because of its importance in blood clotting.
Arg-Gly-Asp Sequence in Fibrinogen
Two Arg-Gly-Asp sequences are present in fibrinogen, both of them in the a-chain. 48 These sequences appear to play a role in the binding of fibrinogen to platelets, since the Arg-Gly-Asp peptides inhibit the binding of fibrinogen to platelets. 49 They also inhibit ADP-induced and thrombin-induced platelet aggregation 4950 ( Figure 3 ). Fibrinogen, however, does not mediate the attachment of fibroblastic cells in assays that are designed to detect attachment to fibronectin and vitronectin. 42 This implies that the receptors on fibroblasts (and probably on many other types of cells) that recognize fibronectin do not recognize fibrinogen. The Arg-Gly-Asp-dependent binding of fibrinogen to platelets must, therefore, be mediated by a receptor different from the fibroblast receptors. Recent studies have provided information on the nature of such receptors.
Adhesion Receptors
Fibronectin and Vitronectin Receptors In Nucleated Cells
The nature of the cell membrane receptors that recognize matrix proteins is incompletely understood, but receptors for laminin 51 " 53 and collagens, 54 as well as for fibronectin 55 and vitronectin, 56 have already been described.
A 140 kd glycoprotein receptor for fibronectin has been isolated from cultured osteosarcoma cells and fibroblasts by affinity chromatography on a large, cell attachment-promoting fragment of fibronectin. 55 The receptor protein can be eluted from the column with an Arg-Gly-Asp-containing peptide, but not with a peptide in which the aspartic acid residue has been replaced by a glutamic acid residue. The 140 kd receptor, when incorporated into liposomes, confers to the liposomes an ability to bind to a surface coated with fibronectin, showing that it retains an activity consistant with the assumed receptor function.
When vitronectin is used as the affinity matrix in an experiment similar to the one that yields the fibronectin receptor, a different receptor is obtained 56 from the same osteosarcoma cells or from fibroblasts. This receptor has two polypeptides with molecular weights of 125,000 and 115,000. These polypeptides can also be obtained by performing the chromatography on an Arg-Gly-Asp-containing heptapeptide coupled to Sepharose. In contrast, the fibronectin receptor does not have suffident affinity for the peptide to bind to such a column. Liposomes containing the vitronectin receptor adhere to a surface coated with vitronectin but not to a surface coated with fibronectin. The two receptors, therefore, have different specificities at the protein level, and, while they both recognize the Arg-Gly-Asp peptides, the vitronectin receptor binds to these peptides better than does the fibronectin receptor. The component polypeptides of a protein complex detected by antibodies that detach myoblasts and other types of cells from culture dishes 57 " 60 have molecular weights similar to those of the fibronectin and vitronectin receptors, suggesting that the same receptors are present in many cell types. In contrast to nucleated cells, which seem to have different receptors for different adhesion proteins, platelets appear to have one receptor with a broad specificity.
A Multifunctional Arg-Gly-Asp Receptor In Platelets?
Work with monoclonal antibodies and genetic studies have implicated the llb/llla glycoprotein (gp) complex at the platelet surface as the main adhesion and aggregation receptor of platelets. Monoclonal antibodies against gp llb/llla can prevent the interaction of platelets with more than one of the adhesion molecules. Thus, single antibodies that prevent the interactions of platelets with fibrinogen, fibronectin, and collagen, have been reported 61 " 68 (reviewed in reference 69). These results suggest that the gp Mb/ Ilia complex serves as a receptor for all of these adhesive proteins. With regard to fibrinogen, there is direct evidence for its binding to gp llb/llla. 70 The central role of gp llb/llla in platelet adhesion is also suggested by the fact that platelets of patients with Glanzmann's thrombasthenia, who have a deficiency of gp llb/llla in their platelets, fail to bind normally to any of the adhesive proteins tested. 7172 The apparent interaction of gp llb/llla with multiple adhesion proteins and the fact that gp llb/llla seems to exist only in platelets 81 " 68 suggest that the adhesive mechanisms of platelets are unique. A further unique feature of platelets is that soluble fibrinogen or fibronectin will only bind to platelets that have been treated with activating agents such as thrombin and ADP
'
Tt~7A even though a large number (4.0 to 6.0 x 10 s ) of the putative receptors (gp llb/llla molecules) are present at the surface of unstimulated platelets as detected using monoclonal antibodies. 64 ' ^ A possible explanation for the availability of the gp llb/llla complex at the platelet surface as an antigen but not as a receptor is that activation is needed to space the complex properly for the expression of the receptor function. 69 It seems likely that not only is there a single receptor on platelets for the various attachment proteins, but there is also a single binding site involved. This idea is supported by the facts that various adhesion proteins compete with one another for binding to Synthetic Arg-Gly-Asp peptides inhibit the binding of at least fibronectin, 50 fibrinogen, 49 and von Willebrand Factor 49 to platelets. This suggests the possibility that the platelet receptor (gp llb/llla complex), unlike the fibroblast receptors, recognizes the ArgGly-Asp sequence regardless of which protein it is part of. The broad specificity of the platelet receptor may be the explanation for the puzzling result that the receptor functions can be inhibited not only by the Arg-Gly-Asp-containing peptides, but also by peptides fashioned after a different sequence from the COOH-terminal end of the fibrinogen ychain.
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The y-chain peptide has the structure His-HisLeu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val and it also inhibits the binding of fibrinogen, fibronectin, and von Willebrand Factor to platelets. 78 ' n There is some similarity between the two sequences (ArgGly-Asp vs Lys-Gln-Ala-G/y-Asp), and they could conceivably interact with the same binding site, if this binding site were designed to accommodate several different structures, as may be the case with the platelet receptor. This and the other special features of the platelet system make it important that the adhesion receptor(s) be identified. The comparison of this receptor with those present in nucleated cells should explain the molecular basis of the apparent ability of this receptor to interact with several proteins.
Different Conformations for Arg-Gly-Asp In Different Proteins?
Regardless of the possibility that a platelet receptor may be capable of recognizing an Arg-Gly-Asp sequence in several proteins, it is clear that in the fibroblastic cells we have studied, the receptors show specificity for individual proteins. 56 Two possible explanations for this specificity are obvious. It could be that while the Arg-Gly-Asp sequence is critical for the receptor-adhesion protein interaction, some surrounding sequences are needed to stabilize the interaction and these latter sequences determine the individual spedficity. The other possibility is that the Arg-Gly-Asp sequence assumes different conformations in different proteins, thus providing the specifidty of the receptor for the ligand. The short peptides may be more flexible than the same sequence in a protein and capable of assuming different conformations, thus mimicking the cell recognition sites of several proteins. At least one other example of a tripeptide recognition sequence functioning in many different proteins exists. The signal for the attachment of NH 2 -linked oligosaccharides onto glycoproteins is Asn-X-Ser/Thr (see reference 80). As seems to be the case with the Arg-Gly-Asp sequences, some of the Asn-X-Ser/Thr sequences are active and some are not.
The Arg-Gly-Asp cell adhesion system clearly has considerable potential to aid in our understanding of cell surface recognition phenomena. As the individual receptors for Arg-Gly-Asp proteins become better known, it should be possible to develop effective antagonists specific for the individual receptors. These could then be used as research probes and possibly as therapeutic agents for modulating physiological responses such as platelet aggregation. There could even be physiological modulators of cell adhesion operating on this principle. No such substances have been identified as yet, but other classes of molecules capable of modulating cell adhesion are known.
Proteoglycans Can Modify Cell Adhesion to Matrices
Proteoglycans are a diversified family of molecules in which the presence of glycosaminoglycan side chains is the primary shared property. Proteoglycans can be integral membrane proteins, 8182 matrix components, 83 " 88 or secreted proteins, 87 and their functions are likely to differ correspondingly. The known or suspected functions of proteoglycans range from the elastic space-filler role of the cartilage proteoglycan 3 to a proposed growth-regulating role of cell surface heparan sulfate proteoglycans. 88 The role of proteoglycans that concerns us here is their involvement in cell adhesion.
Proteoglycans can either promote cell attachment or inhibit it. A cell membrane-embedded form of heparan sulfate proteoglycan may mediate the attachment of cells to collagen. 82 Moreover, heparan sulfate proteoglycans are most abundant in newly formed cell adhesions, 89 their localization in matrices coincides with those of the other adhesion proteins fibronectin and laminin, 8485 and they are also present in adhesion particles called adherons. 90 Chondroitin sutfate proteoglycans, in contrast, although present in extracellular matrices, are relatively more abundant at the cell surface 84 ' M and in old adhesion sites about to be broken. 89 One particular chondroitin sulfate proteoglycan, which is produced by rat yolk sac tumor cells, is an abundant secretion product of such cells 8791 and this secreted proteoglycan may be exerting an adhesion disrupting effect through its binding to fibronectin and collagen. 92 The structure of the core protein of the yolk sac tumor proteoglycan has been determined from cloned cDNA. 93 It shows that the 104-amino acid core protein contains an uninterrupted 49-amino acid serine-glycine repeat that clearly functions as the attachment site for the numerous glycosaminoglycan sidechains of this proteoglycan (Figure 4 ). Since this is the first structure of its kind, it is difficult to say much about the structure-function relationships in the proteoglycan. However, considering the fact that about one-half of the core is devoted to carrying glycosaminoglycan, it seems that the molecule may well be designed to function primarily through interactions of its glycosaminoglycan component. This proteoglycan can bind both to type I collagen and to fibronectin, and as it binds to these proteins, it prevents their cell attachment function. 92 This apparently happens because the proteoglycan covers up the cell attachment site that, at least in fibronectin, is adjacent to the glycosaminoglycan binding site to which the proteoglycan binds ( Figure  5 ). The yolk-sac tumor proteoglycans binds poorly to type IV collagen and fails to prevent its cell attachment activity.
The main cartilage proteoglycan and model glycosaminoglycans inhibit cell attachment in a manner similar to the yolk-sac tumor proteoglycan. creted into tumor ascites fluid or culture medium of these cells is high enough so that the proteoglycan, despite its relatively low affinity for collagen and fibronectin, can bind to them and act as an adhesion inhibitor. 9192 It remains to be seen what effect this might have on the biological properties of the tumor cells in vivo. The adhesion pattern obtained in vitro would suggest that the tumor cells might readily traverse loose connective tissue, as they could easily break their adhesive connections to type I collagen and fibronectin in any given location and move on. In contrast, they should be able to attach firmly to the type IV collagen of basement membranes in locations such as small blood vessels which could facilitate the establishment of secondary tumor foci. Understanding of the biological effects of cell matrix interactions will be useful in assessing the possible consequences of matrix changes in phenomena as complex as tumor invasion. In this regard, the available information, while rudimentary, is rapidly expanding.
Biological Effects of Cell-Matrix Interactions
Extracellular Matrices In Cell Anchorage
The most obvious consequence of cell matrix interactions is cell attachment that results in anchoring of cells. However, the effects of cell-matrix interactions clearly go well beyond mere anchoring of cells and include cellular responses such as increased migration, differentiation, and stimulated or arrested growth. In considering the effects of extracellular matrix on cells, it is important to note that there are three essentially independent aspects of the relationship of a given cell with extracellular matrix: 1) the production of extracellular matrix proteins by the cell, 2) the deposition of the proteins produced into an insoluble matrix, and 3) the ability of the cells to interact with this matrix and with matrices made by other cells. Normal cells typically participate in all three of these aspects, while tumor cells are frequently deficient in one or more of these areas.
The interaction of cells with adhesive matrix proteins is manifested through the attachment and spreading of the cells only if the matrix protein is insolubilized on a surface or in a matrix. Why the soluble fibronectin, for example, which is abundant in plasma, tissue fluids, and cell culture media should have little effect on the attachment of cells to solid phase fibronectin is not entirely clear. It appears that the affinity of the interaction of a single fibronectin molecule with the cell surface is low 4297 and that cooperative binding of many fibronectin molecules on a solid surface is required for a productive interaction to take place. Very high concentrations of fibronectin or its cell attachment fragments in solution can indeed inhibit attachment of cells to fibronec-(j n «,«, 98 5 u c n a situation is illustrated schematically in Figure 6 . This inhibition of attachment is readily demonstrable using the Arg-Gly-Asp-containing synthetic peptides. Because these peptides affect cell attachment in a competitive, nontoxic manner, they are proving to be useful as probes for the role of cell adhesion in various biological systems.
One of the questions we have studied using the peptides concerns the attachment mechanisms of cultured cells. When a number of different established cell lines and primary cultures were treated with soluble Arg-Gly-Asp peptides, it was shown that in each case the attachment of the cells to the culture substratum was susceptible to detachment with the peptides, while it was unaffected by closely related control peptides. 45 The detaching effect of the ArgGly-Asp peptides on cultured cells would seem to suggest that fibronectin is the adhesion promotor responsible for the substratum attachment of the cells. However, since the peptides interfere with the function of other proteins, notably vitronectin, which would be present in the cultures either derived from serum used in the culture medium or from the cells, one can only conclude that an Arg-Gly-Asp-dependent mechanism is involved. Similar considerations apply to experiments where Arg-Gly-Asp-containing peptides have been shown to interfere with development of cultured embryos. 99 The attachment to collagen, on the other hand, does not seem to play a primary role in the adhesion of cultured cells. 45 Human and bovine endothelial cells are among the cells sensitive to the detaching effect of the ArgGly-Asp peptides. 45 This suggests that endothelial cells (at least in vitro) depend on fibronectin or possibly some other Arg-Gly-Asp-containing protein for their substrate attachment. That the attachment protein is fibronectin is suggested by the fact that endo- thelial cells produce fibronectin in culture. 100 and apparently also thrombospondin 112113 become incorporated into the membrane of endothelial cells. Proper adherence of endothelial cells to this underlying basement membrane is very important for the integrity of the continuous nonthrombogenic endothelial lining of blood vessels. To what extent any one or more of these components might contribute to the attachment of endothelial cells in vivo is not well understood, but at least fibronectin and laminin probably play a role in this process.
That fibronectin and other adhesive matrix components are important for anchorage of cells in vivo, is suggested by a number of observations. Latex particles coated with fibronectin or laminin fail to become translocated in embryonal tissues where uncoated particles and particles coated with nonadhesive proteins migrate to locations quite distant from the point of where they were introduced. 114 Precursors of red blood cells in the bone marrow possess the ability to attach to fibronectin-coated surfaces, whereas immature red cells and reticulocytes lose this property as they differentiate and the circulating mature red blood cells lack this ability. 115 These results suggests that the cells belonging to the red cell lineage stay in the bone marrow as long as they express the fibronectin receptor and become released as they mature and lose the receptor. The fibronectin to which the precursor cells adhere in the bone marrow is presumably that of the supporting reticular cells. It will be interesting to see whether differences in adhesive receptors might explain the tendency of lymphomas to localize in tissue while leukemia cells, which can be very similar to lymphoma cells in all other respects, are predominantly present in the circulation.
Extracellular Matrices In Cell Migration
Cells respond to a concentration gradient of an adhesive protein on a surface by migrating toward the higher concentration. 116 " 7 This phenomenon, called haptotaxis, is a special form of chemotaxis in that it depends on a concentration gradient of an insoluble ligand rather than a solute. Haptotaxis appears to be important in cell migrations during development, because tissues where migration takes place are generally rich in fibronectin 118 and the cells that are known to migrate in such areas can be shown to respond to fibronectin by increased migration rather than simply attaching to it. 119 Extracellular matrices are thus likely to be guiding cells to their appropriate destinations during development. The subtly differing specificities of the receptors for the Arg-Gly-Asp sequences in different adhesion proteins may play a role in such guidance. Now that some of these and other adhesion receptors have been isolated, 51 " 56 it will be possible to test this hypothesis.
Adhesion proteins also probably play a role in the migratory behavior of malignant cells which results in invasion and metastasis. That this is the case is suggested by the lack of extracellular matrix deposition by many malignant cells 484 ' 85 and the increased metastatic activity of cells treated with soluble laminin. 120 ' 121 The role of extracellular matrices in malignancy has been recently reviewed 122 and will not be considered further here.
Effects of Extracellular Matrices on Cell Growth and Differentiation
Most cells, in order to grow at all in vitro, require attachment proteins from serum, 123 which contains fibronectin and vitronectin. Serum-free media will usually have to be supplemented with one of these proteins to be supportive of cell growth. 124 Moreover, senescence of cultured fibroblasts can be delayed by growing the cells on an extracellular matrix made by endodermal cell. 125 Some cells fare best if provided with a three-dimensional lattice of matrix with which to interact (e.g., reference 126). It may be that the collagen gel helps create a geometry more reminiscent of the in vivo situation than would be attained in a monolayer culture.
In addition to promoting growth, extracellular matrices can also affect the differentiation of cells. Several lines of evidence suggest that fibronectin plays a role in directing differentiation and morphogenetic movements of certain cells. Myoblasts, which initially express fibronectin, lose it prior to their fusion into myotubes, 127 and the addition of fibronectin to cultures of myoblasts inhibits their fusion. 128 Addition of fibronectin to cultures of differentiated chondrocytes makes the cells assume a fibroblastic phenotype with lowered synthesis of cartilage components, such as type II collagen and proteoglycan. 128 ' 130 Primary cultures of epithelial cells retain their differentiated properties if grown within a collagen gel. 126 A particularly striking effect on differentiation is obtained when neuronal cells are cultured on la- Figure 7) . Similar effects can also be obtained with fibronectin but at much higher concentrations. 134 In view of the pronounced effects of laminin on neurite formation, it is interesting that tissue damage in the brain induces transient expression of laminin during the regenerative phase. 135 A similar transient appearance of laminin is seen in the liver after carbon tetrachlorideinduced liver damage. 136 These results suggest a role for laminin in cell differentiation and tissue organization. In agreement with such a suggestion, laminin has been shown to be one of the first known matrix components to be expressed in the developing mammalian embryo. 137 Its expression has also been correlated with the development of kidney tubuli in the embryo. 138 The influence that matrices have on growth and on differentiation-related events may be exerted through interactions separate from those supporting anchorage. One explanation for the growth-promoting effects of matrices is that matrices bind growth factors 139 and another possibility is that they make cells responsive to soluble growth factors. 140 There is also some evidence that extracellular matrix proteins themselves may contain growth-promoting and differentiation-inducing sequences. Thus, fragments of fibronectin from the collagen-binding region of the molecule reportedly promote the expression of transformed phenotype in cells infected with Rous sarcoma virus, 141 and other types of fibronectin fragments have been found to be mitogenic for fibroblasts. 142 Moreover, vitronectin contains the suspected mitogen somatomedin B. 21 Recent advances in the isolation of matrix components and their receptors should make it possible to analyze the molecular mechanisms of the growth and differentiation-promoting matrix interactions.
Future Prospects
Most of what we currently know about the role of extracellular matrix interactions has been extrapolated from in vitro assays. With the exception of the collagen field, 143 a major difficulty preventing us from learning more about the functions of matrix molecules in vivo has been the lack of natural mutations that would give information on the consequences about the lack or altered function of matrix proteins. The tools may now be at hand to study these questions by experimentally altering the structure and expression of matrix proteins.
Mutant mice that lack a functional gene for type I collagen a, chain have been obtained by random retroviral integration into the germ line. 144 It is not yet possible to alter an individual gene in a targeted fashion, but cloned genes can be transferred into animals where they are expressed. It may also be possible to interfere with the in vivo expression of matrix proteins or their receptors in a controlled way. One could, for example, ask whether interactions of the fibronectin receptor play a role in the development and functioning of a given cell type. This question could be approached by generating transgenic mice expressing antisense fibronectin receptor RNA under the control of an enhancer specific for a particular cell type. Such enhancer sequences are already available for many cell types. One can also envision an experiment where a gene, the product of which is suspected of affecting the metastatic potential of tumor cells, would be either turned off in cells that express it or introduced into cells that normally do not have it. This would allow one to assess the metastatic potential of the altered cells. It is safe to predict that such experiments will in the next several years provide us with an improved understanding of the significance of cell-matrix interactions. This will form the basis of therapeutic interventions with compounds designed to modulate the matrix interactions such as the Arg-Gly-Asp peptides or their more potent or more selective successors.
